Piper Sandler Increases Phreesia (NYSE:PHR) Price Target to $34.00

Phreesia (NYSE:PHR) had its target price hoisted by research analysts at Piper Sandler from $33.00 to $34.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s price objective indicates a potential upside of 21.04% from the company’s current price.

Several other equities research analysts have also issued reports on PHR. Mizuho initiated coverage on Phreesia in a research note on Wednesday, August 27th. They set an “outperform” rating and a $36.00 price objective for the company. Citigroup reissued a “buy” rating on shares of Phreesia in a research note on Wednesday, May 28th. Truist Financial lifted their price objective on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, May 29th. Canaccord Genuity Group dropped their price target on Phreesia from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Thursday, May 29th. Finally, DA Davidson initiated coverage on Phreesia in a research note on Friday. They set a “buy” rating and a $33.00 price target for the company. Thirteen equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $33.31.

Phreesia Price Performance

NYSE:PHR opened at $28.09 on Friday. The firm has a market capitalization of $1.67 billion, a price-to-earnings ratio of -66.88 and a beta of 0.72. Phreesia has a 52-week low of $17.07 and a 52-week high of $32.76. The stock has a fifty day moving average of $28.34 and a 200 day moving average of $26.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.08. The company had revenue of $117.26 million during the quarter, compared to analyst estimates of $116.39 million. Phreesia had a negative return on equity of 9.00% and a negative net margin of 5.35%.The firm’s quarterly revenue was up 14.9% on a year-over-year basis. During the same quarter last year, the company earned ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. On average, research analysts expect that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Activity

In other news, General Counsel Allison C. Hoffman sold 1,245 shares of Phreesia stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $26.89, for a total value of $33,478.05. Following the transaction, the general counsel owned 136,978 shares in the company, valued at approximately $3,683,338.42. The trade was a 0.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider David Linetsky sold 17,445 shares of Phreesia stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $29.73, for a total value of $518,639.85. Following the completion of the transaction, the insider owned 174,002 shares in the company, valued at approximately $5,173,079.46. This represents a 9.11% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 119,874 shares of company stock valued at $3,587,618. 5.50% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Raymond James Financial Inc. increased its holdings in shares of Phreesia by 2.7% in the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after buying an additional 375 shares during the period. Diversified Trust Co increased its holdings in shares of Phreesia by 1.0% in the second quarter. Diversified Trust Co now owns 45,042 shares of the company’s stock worth $1,282,000 after buying an additional 426 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Phreesia by 2.8% in the second quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company’s stock worth $569,000 after buying an additional 540 shares during the period. Arcadia Investment Management Corp MI increased its holdings in shares of Phreesia by 0.7% in the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company’s stock worth $2,371,000 after buying an additional 615 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Phreesia by 9.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company’s stock worth $251,000 after buying an additional 792 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.